Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market ...
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...
The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
Eli Lilly & Co. is ramping up its legal campaign against companies that were temporarily allowed to make and sell copycat ...
Data readouts over the next six months could set expectations for how the highly lucrative market for weight loss therapies ...